Skip to main content

Table 2 Influence of RAMP-O on composite milk NAGase

From: Therapeutic effect of polysaccharide fraction of Atractylodis macrocephalae Koidz. in bovine subclinical mastitis

RAMP-O (mg)

No. of cows

Weeks post treatment

0†

1

2

3

16

6

52.07 ± 12.50

46.75 ± 10.09*

46.31 ± 9.79*

33.91 ± 9.27a*

32

6

52.46 ± 12.24

46.18 ± 9.49*

25.36 ± 6.77A**

23.79 ± 5.47A**

48

6

52.11 ± 11.35

27.27 ± 8.09A**

24.97 ± 6.85A**

21.09 ± 3.44A**

Control

6

52.66 ± 12.12

52.90 ± 12.07

55.09 ± 11.73

53.13 ± 11.81

  1. NAGase of composite milk in cows before and after subcutaneous injection of RAMP-O in the areas of supramammary lymph node (mean ± S.E. U/L)
  2. aP < 0.05, AP < 0.01, compared with the control in the same time
  3. *P < 0.05, **P < 0.01, compared with pretreatment
  4. †Pretreatment
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us